|
|
|
| The Influence of Suhuang Zhike Capsule Combined with Seretide on the Serum Levels of TNF-α, TGF-β1 and IgE of Patients with Cough Variant Asthma |
| WANG Ning, HUO Xiaoying, CHEN Baoqing, et al |
| Xi'an Fourth Hospital, Shaanxi Xi'an 710004, China |
|
|
|
|
Abstract Objective: To analyze the influence of Suhuang Zhike capsule combined with seretide on the serum levels of tumor necrosis factor-α(TNF-α), transforming growth factor β1(TGF-β1) and immunoglobulin E (IgE) of patients with cough variant asthma. Methods: 90 cases of cough variant asthma admitted from March 2015 to September 2016 in our hospital were selected and divided into the control group and the observation group with 45 cases in each group. The control group was treated with seretide, while the observation group was treated with Suhuang Zhike capsule based on the control group, of the serum levels of TNF-α, TGF-β1, IgE, eosinophils (Eos) count, fractional exhaled nitric oxide (FeNO), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), cough symptoms integral, curative effect and incidence of adverse reactions were compared between two groups after treatment. Results: After treatment, the serum levels of TNF-α, TGF-β1, IgE, Eos, FeNO of observation group were significantly lower than those of the control group(P<0.05), FVC, FEV1, cough symptoms integral and total effective rate of observation group were obviously higher than those of the control group (P<0.05). No severe adverse reactions was found in both groups after treatment(P>0.05). Conclusion: Suhuang Zhike capsule combined with seretide is effective in the treatment of patients with cough variant asthma, which could reduce the levels of serum TNF-α, TGF-β1, IgE.
|
|
|
|
|
|
[1] 马立波,陈复辉.咳嗽变异性哮喘和支气管哮喘的关联[J].现代医学,2015,43(7):935~938.
[2] 胡红.咳嗽变异性哮喘诊疗新进展[J].疑难病杂志,2015,14(2):111~113.
[3] 郭立峰,刘晓虎,张俊芳,等.孟鲁斯特钠、沙美特罗替卡松联合小剂量氨茶碱对成人咳嗽变异性哮喘患者血清TNF-α、TGF-β1和IgE水平的影响[J].解放军医药杂志,2016,28(S1):10~12.
[4] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2009版)[J].中华结核和呼吸杂志,2009,32:407~413.
[5] 许银姬,周明娟,梁桂兴,等.咳嗽变异性哮喘患者规范治疗2年的随访研究[J].广东医学,2016,37(14):2104~2107.
[6] 王传海,李承红.舒利迭与孟鲁司特联用对咳嗽变异性哮喘患者的疗效观察[J].中国医院药学杂志,2016,36(1):50~53.
[7] 刘继华.中医分期论治咳嗽变异性哮喘的验案一则[J].天津中医药,2017,34(10):686~687.
[8] 范冀缓,王莉梅,柴劲,等.咳嗽变异性哮喘患者运用苏黄止咳胶囊的循证治疗[J].中国临床研究,2015,28(4):513~516.
[9] 王传海,李承红.咳嗽变异性哮喘28例临床分析[J].临床肺科杂志,2016,21(1):166~168.
[10] 徐翼,盛泽波.孟鲁斯特钠、沙美特罗替卡松联合小剂量氨茶碱对成人咳嗽变异性哮喘患者血清TNF-α、TGF-β1和IgE水平的影响[J].海南医学,2017,28(20):3272~3275. |
|
|
|
2018, Vol. 24 
